baber/WOPTO huggingface dataset:
Patent FI-962285-A0 (FI)
Inventor: SWANDE JERKER
IPC: A63C1/30
Filed: 1996-05-31
Abstract: PCT No. PCT/SE94/01101 Sec. 371 Date Jun. 3, 1996 Sec. 102(e) Date Jun. 3, 1996 PCT Filed Nov. 18, 1994 PCT Pub. No. WO95/15199 PCT Pub. Date Jun. 8, 1995An ice-skate blade includes a central main runner and side-runners positioned on opposite sides of the main runner. The blade includes three zones separated in the longitudinal direction of the blade, namely an essentially central glide zone 8, 9, having one or more runners located on the same level, and a rear zone and a front zone having side-runners which extend on respective sides of the main runner and which are located at a higher level than the main runner, so as to grip the ice only when the blade is tilted. The side-runners extend along the full length of the main runner.
Patent FI-962700-A0 (FI)
Inventor: RAESAENEN JUHA
IPC: H04Q3/42
Filed: 1996-06-28
Abstract: The invention relates to an adapter equipment (IWF), a method and an arrangement for setting up a data call terminating at a subscriber in a telecommunication network. In the invention, adaptation functions of two or more data services are integrated into a single adapter pool that has one common MSISDN number shared by all the data services. After the connection has been set up, the IWF does not try to synchronize itself according to any data service towards another network but it monitors a traffic channel arriving from the other network (ISDN, PSTN) in order to identify the data service used by the calling terminal equipment. After the IWF has identified the data service, it starts operating in the manner required by the identified data service and data transmission may begin.
Patent FI-974221-A0 (FI)
Inventor: JAEKAERAE JUKKA
IPC: D21C9/14
Filed: 1997-11-13
Abstract: The invention relates to a process for the bleaching of chemical pulp, wherein the pulp is delignified and/or bleached with chlorine dioxide or with a combination of chlorine dioxide and a per-compound, and additionally the pulp is chelated in order to bind heavy metals, such as Fe, Mn and/or Cu, to a chelate complex. The chelate complex is selected from the group made up of N-bis-[(1,2-dicarboxylethoxy)-ethyl]-amine, N-bis[(1,2-dicarboxylethoxy)-ethyl]-aspartic acid and N-tris-[(1,2-dicarboxylethoxy)-ethyl]-amine, and the alkali metal and earth-alkali metal salts of these, and the chelating treatments are carried out simultaneously by combining the chelating chemical with the pulp in the same bleaching stage as chlorine dioxide.
Patent FI-980122-A0 (FI)
Inventor: BROWNING JEFFREY L
IPC: A61P25/00
Filed: 1998-01-20
Abstract: This disclosure relates to compositions and methods comprising "lymphotoxin-² receptor blocking agents" which block lymphotoxin-² receptor signalling. Lymphotoxin-² receptor blocking agents are useful for treating lymphocyte-mediated immunological diseases, and more particularly, for inhibiting Th1 cell-mediated immune responses. This disclosure relates to soluble forms of the lymphotoxin-² receptor extracellular domain that act as lymphotoxin-² receptor blocking agents. This disclosure also relates to the use of antibodies directed against either the lymphotoxin-² receptor or its ligand, surface lymphotoxin, that act as lymphotoxin-² receptor blocking agents. A screening method for selecting soluble receptors, antibodies and other agents that block LT-² receptor signalling is provided.
Patent FI-991209-A0 (FI)
Inventor: HEINAESENAHO HANNU
IPC: E02D3/026
Filed: 1999-05-28
Abstract: The invention discloses a power transmission arrangement for a compactor, in which a roller is installed to both end-pieces of a roller frame. In both end-pieces, there are bearing assemblies supporting the roller. In addition, in at least one end of the roller there is a hub motor, which is arranged to rotate the roller. The bearings of the hub motor form the bearing assembly supporting the end of the roller. In addition, the roller is supported from the end-piece with the aid of the hub motor and a universal joint. The universal joint transmits moment and permits a variation in the angle between the roller and the end-piece.
Patent IL-62830-A0 (IL)
Title: Water saving toilet system
IPC: E03D5/10
Filed: 1981-05-10
Abstract: A toilet system comprising a bowl (10), a valve (S) for supplying flush water to the bowl, an attrition chamber (20a) to which the effluent in the bowl (10) is transferred by a motor-driven discharge pump connected to the attrition chamber (20a) for inducting the effluent from the bowl into the attrition chamber and discharging the treated effluent from the attrition chamber, a powerdriven hydraulic attrition impeller (22) within the attrition chamber (20a) for effecting hydraulic attrition of the solid matter in the effluent while in the attrition chamber, and a control circuit for effecting sequential operation such that discharge and attrition are commenced substantially simultaneously, followed by introduction of flush water, termination of the discharge, termination of the flush water and, finally, termination of the attrition. There are one or more fountain heads (32) supported inside the rim structure to project solid, fanshaped sheets of flush water downwardly on the inner surface of the bowl (10).
Patent IL-66497-A0 (IL)
Title: Gunnery training apparatus
IPC: F41G3/26
Filed: 1982-08-09
Abstract: @ A gunnery training system comprising a fire control unit located at a trainee location and including an aiming sight (12), an aiming controller (18), and a trigger (20); a video display (22) viewable through the aiming sight and providing a field of view through the aiming sight corresponding to the actual view of a target through the aiming sight of an actual gun; apparatus (32, 34) for sensing the orientation of the trainee's line of sight provided by the operation of the aiming controller by the trainee; apparatus for determining the trajectory of a simulated projectile relative to the target provided by the sensed orientation produced by the trainee's operation of the aiming controller; a library (44) of video records of actual projectile trajectories and impacts for various orientations of an actual gun relative to the target shown on the display; and apparatus responsive to operation of the trigger and to an output from the determining apparatus for selecting a video record from the library and displaying it on the display in a time relationship to trigger actuation.
Patent IL-66511-A0 (IL)
Title: Novel 6alpha-methylprednisolone derivatives,processes for their preparation and pharmaceutical preparations containing them
IPC: C07J5/00
Filed: 1982-08-10
Abstract: 6 alpha -Methylprednisolone derivatives of Formula I    <IMAGE>  (I) wherein R1 is 1-oxoalkyl of 2-6 carbon atoms or benzoyl and R2 is 1-oxoalkyl of 2-6 carbon atoms, are pharmacologically efficacious compounds, e.g., as antiinflammatories.
Patent IL-72234-A0 (IL)
Title: Water-soluble rifampicin derivatives
IPC: A61P31/04
Filed: 1984-06-27
Abstract: The present invention is directed to new water soluble rifampicin derivatives which are suitable for preparing aqueous solutions for oral or parenteral administration. The new derivatives of the invention are 4 and/or 8 alkanoyl or alkanoyloxyalkyl esters of rifampicin and possess essentially the same antibacterial activity of this widely known antibiotic substance.
Patent IL-72398-A0 (IL)
Title: Pristinamycin derivatives,process for the preparation thereof and pharmaceutical compositions containing them
IPC: C07K5/078
Filed: 1984-07-12
Abstract: The invention provides new pristinamycin IIB derivatives of the formula:    <IMAGE>  (I)  in which R represents alkylthio substituted by (i) alkylamino or dialkylamino of which the alkyl parts can form a pyrrolidin-1-yl, piperidino, azetidin-1-yl, azepin-1-yl, morpholino, thiomorpholino or piperazin-1-yl ring (optionally substituted by alkyl), or (ii) pyrrolidin-2-yl or pyrrolidin-3-yl, piperidin-2-yl, piperidin-3-yl or piperidin-4-yl, azetidin-2-yl or azetidin-3-yl or azepin-2-yl, azepin-3-yl or azepin-4-yl; a radical Het-S-, in which Het is pyrrolidin-3-yl, piperidin-3-yl or piperidin-4-yl, azetidin-3-yl or azepin-3-yl or azepin-4-yl optionally N-alkylsubstituted; or dialkylamino of which the alkyl parts can form a pyrrolidin-1-yl, piperidino, azetidin-1-yl, azepin-1-yl, morpholino, thiomorpholino or piperazin-1-yl ring (optionally substituted by alkyl), the said alkyls having 1 to 5 carbon atoms each in a linear or branched chain. The compounds of the formula (I) are useful as antimicrobial agents when used in association with known synergistines or synergistines of the formula:    <IMAGE> (V)
Patent IL-76877-A0 (IL)
Title: Monoclonal antibodies for human non-small cell lung carcinomas
IPC: G01N33/48
Filed: 1985-10-29
Abstract: An antigenic composition purified from normal human serum or the culture medium of human non-small cell lung carcinoma cells comprising a non-denatured glycosylated Form I L3 protein, said protein having the following N-terminal amino acid sequence : <IMAGE> a molecular weight of about 94,000 daltons as determined by SDS polyacrylamide gel electrophoresis under reducing conditions, and N-linked glycoside residues in which the terminal residues of the N-linked glycoside residues are sialic acid residues.
Patent IL-79379-A0 (IL)
Title: Carboxylic acid derivatives,process for the preparation thereof and pharmaceutical compositions containing them
IPC: C07C231/12
Filed: 1986-07-10
Abstract: PCT No. PCT/EP86/00406 Sec. 371 Date Mar. 12, 1987 Sec. 102(e) Date Mar. 12, 1987 PCT Filed Jul. 10, 1986 PCT Pub. No. WO87/00521 PCT Pub. Date Jan. 29, 1987.This invention relates to carboxylic acid derivatives and their use thereof. The compounds are useful in treatment of various diseases such as diabetes, prediabetic conditions, adipositas ailments or atherosclerosis.
Patent IL-79785-A0 (IL)
Title: Tetraoxo compounds,their preparation and pharmaceutical compositions containing them
IPC: A61K31/44
Filed: 1986-08-20
Abstract: Tetraoxo compounds of the Formula (I)    <IMAGE>  (I)  wherein R1 is an alkyl, alkenyl, phenylalkyl or cycloalkylalkyl group, R2 and R3 are each independently an alkyl or phenyl group or together denote an alkylene group, W is a (CH2)n-Q group, in which n is 2 to 10 and Q is (a) a displaceable leaving group X, or (b) Z-R4, where Z is a 1-piperazinyl group, and R4 is in position 4, and is hydrogen or a phenyl, substituted phenyl, N-heteroaryl or substituted N-heteroaryl group; and salts and acid addition salts of said compound, and a method for their preparation. Selected compounds of Formula (I) have been found to have central nervous system affecting activity.
Patent IL-82530-A0 (IL)
Title: Manufacture of meat-based products
IPC: A23L13/00
Filed: 1987-05-14
Abstract: A process of producing an evenly cooled comminute of meat particles ready for forming comprises forming a primary comminute from fresh meat, on a first comminution device (1) cooling the particles of the primary comminute into a coherent strip (10) on a moving refrigerated surface of a drum (7) and subjecting the strip to a secondary comminution, on a secondary comminution device (13) with a reduction in particle size and a temperature equalization.
Patent IL-94847-A0 (IL)
Title: Control of aberrant expression vector accumulation during fermentation procedures
IPC: C12R1/19
Filed: 1990-06-22
Abstract: The present invention provides a method for preventing the accumulation of aberrant expression vectors during fermentation processes which rely on the expression of an expression vector coded gene for production of a polypeptide product of interest. Antibiotics are added at approximately the time at which product expression begins.
Patent AU-PQ810900-A0 (AU)
Title: Viral variants and methods of using same
IPC: C12Q1/68
Filed: 2000-06-09
Abstract: The present invention relates generally to viral variants exhibiting reduced sensitivity to agents and in particular nucleoside analogues. More particularly, the present invention is directed to hepatitis B virus variants exhibiting complete or partial resistance to nucleoside analogues. The variants may also comprise corresponding mutations affecting immunological interactivity to viral surface components. The present invention further contemplates assays for detecting such viral variants which assays are useful in monitoring anti-viral therapeutic regimes and in developing new or modified vaccines directed against viral agents and in particular hepatitis B virus variants. The present invention also contemplates the use of the viral variants to screen for agents capable of inhibiting infection, replication and/or release of the virus.
Patent FI-20000254-A0 (FI)
Inventor: RATA ILKKA
IPC: B05C11/04
Filed: 2000-02-08
Abstract: The invention relates to a composite blade, in which there is an essentially plate-like blade component (13) with a composite-construction and retention members arranged in its rear part (14). The blade (10) is intended to be installed in a special blade holder (11) with the said retention members remaining in the throat (15) of the blade holder (11). The retention members are formed of profiling (16) arranged as a lateral extension of the blade component (13). The profiling (16) extends essentially over the entire length of the blade (10) and is of the same piece as the blade component (13). <IMAGE>
Patent FI-20021345-A0 (FI)
Inventor: SYRJAENEN TARU
IPC: B42D15/00
Filed: 2002-07-08
Abstract: The present invention relates to a method of producing a layered and flexible information page (10) of a secure document by laminating layers of the information page together. To make the information page in an easy and simple manner, the method comprises: forming a separation layer (9a) of a material that prevents layers (3, 4) from laminating together, placing layers (1 to 6) of the layered information page on top of each other in such a manner that the separation layer (9a) partially separates two layers (3, 4) from each other, laminating the layers (1 to 6) together, and forming a connection piece (14) by removing a part (12) from the laminated information page (10) by making a cut (11a) extending to the separation layer and by removing the part (12) separated by the cut. <IMAGE>
Patent FI-20025047-A0 (FI)
Inventor: MATIKAINEN EERO
IPC: F24F13/24
Filed: 2002-10-18
Abstract: An exhaust outlet is arranged in offset with respect to an inlet. A flow duct is formed to guide the air flow from the inlet towards the outlet. A sound attenuating material is fitted within the flow duct. An independent claim is also included for air blowing method.
Patent FI-20031008-A0 (FI)
Inventor: MOILANEN TEUVO RISTO
IPC: F16N25/02
Filed: 2003-07-03
Abstract: The invention relates to an arrangement in connection with a central lubrication system. The arrangement includes a lubricant vessel, a pump unit, a control unit, pipe systems, a pressure monitor unit, at least one lubricant feeder provided with at least one piston which moves due to the influence of the pressure of a lubricant present in the pipe system/object to be lubricated, and a movement monitor unit to monitor the operation of the feeder. The movement monitor unit includes a sensor part mounted to a nipple manufactured from a weakly magnetable material. The nipple includes a permanent magnet to generate a magnetic field, and a sensor for detecting movement of the piston, and an electronics part which processes a signal received from the sensor and forwards this processed signal to the control unit.
Patent FI-20115711-A0 (FI)
IPC: D21C/
Filed: 2011-07-01
Abstract: The present invention concerns a method of producing dissolving pulp, wherein bleached paper pulp produced by kraft pulping is used as a raw-material pulp, the method being carried out by cold alkali treatment by mixing the raw-material pulp with a concentrated alkali solution such that the mixture of the pulp and the alkali solution contains 50 - 220 g/1 alkali and the solution is allowed to be absorbed into the pulp at a temperature of 20 - 50 °C. The alkali is allowed to act on the pulp in order to dissolve hemi celluloses into it and the hemicelluloses-containing alkali solution is separated from the pulp, i.e. from the dissolving cellulose pulp. Finally, the separated alkali solution is concentrated and recycled to the feed of the cold alkali stage.
Patent IL-112457-A0 (IL)
Title: Glycopeptide antibiotic derivatives
IPC: A61P31/00
Filed: 1995-01-26
Abstract: A new glycopeptide molecule is inserted into the antibiotic group and both components are mixed with a standard pharmaceutical carrier.
Patent IL-115400-A0 (IL)
Title: Carbon containing vascular graft and method of making same
IPC: B29L23/00
Filed: 1995-09-22
Abstract: A carbon containing vascular graft formed of expanded polytetrafluoroethylene and activated carbon admixed with at least a portion of the expanded polytetrafluoroethylene. A bioactive substance may be incorporated in the carbon containing vascular graft.
Patent IL-124749-A0 (IL)
Title: Toothbrush with pump
IPC: A61C17/22
Filed: 1996-12-10
Abstract: PCT No. PCT/FI96/00653 Sec. 371 Date Nov. 5, 1997 Sec. 102(e) Date Nov. 5, 1997 PCT Filed Dec. 10, 1996 PCT Pub. No. WO97/22281 PCT Pub. Date Jun. 26, 1997A pump toothbrush includes a brush portion, a grip portion and an intermediate arm portion. The grip portion includes a container portion for dental cleansing medium and is connected to the brush portion by way of a pump device to feed the dental cleansing medium into the brush portion through the intermediate arm portion. The pump device includes a frame portion that is arranged between the container portion and the arm portion. The frame portion is provided with a recess located perpendicularly with respect to the longitudinal axis of the pump toothbrush. An adjusting body forming an inner portion of the pump device is fitted into the recess in the frame portion. The adjusting body possesses an axial outwards open intermediate space that functions as a chamber in the pump device. The intermediate space in the adjusting body is closed by a flexible pressure membrane. In addition, inlet and outlet valves are arranged in the adjusting body to enable connection between and transfer of dental cleansing medium from the container portion to the brush portion through the inlet and outlet valves when pressure is applied to the flexible pressure membrane.
Patent IL-130083-A0 (IL)
Title: 3-Pyridyl enantiomers and their use as analgesics
IPC: A61K31/485
Filed: 1997-12-10
Abstract: The present invention relates to a method of controlling pain in mammals, including humans, comprising administering to a mammal or patient in need of treatment thereof selected compounds of formula (I) or a pharmaceutically acceptable salt thereof. The invention further relates to selected (R) and (S) compounds of formula (I) which are useful as analgesics as well as neuronal cell death preventors and anti-inflammatories.
Patent IL-130273-A0 (IL)
Title: N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate a pharmaceutical composition containing the same and the use thereof
IPC: A61K31/495
Filed: 1997-12-05
Abstract: PCT No. PCT/JP97/04451 Sec. 371 Date Jun. 14, 1999 Sec. 102(e) Date Jun. 14, 1999 PCT Filed Dec. 5, 1997 PCT Pub. No. WO98/25914 PCT Pub. Date Jun. 18, 1998Hydrates of N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide, which are stable against heat, light, and humidity, are described. The material is easy to handle under ordinary interior humidity conditions. N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate is useful as a medicament in the treatment of amnesia and senile dementia.
Patent IL-133245-A0 (IL)
Title: Regeneration of metal cvd precursors
IPC: C23C16/00
Filed: 1999-12-01
Abstract: A process for recovering a 1,1,1,5,5,5-hexafluoro-2,4-pentanedione ligand from a metal-ligand complex byproduct such as Cu<sup>+2</sup>(1,1,1,5,5,5-hexafluoro-2,4-pentanedionate<sup>-1</sup>)<sub>2</sub>, comprising: providing a copper-ligand complex byproduct of Cu<sup>+2</sup>(1,1,1,5,5,5-hexafluoro-2,4-pentanedionate<sup>-1</sup>)<sub>2</sub> in a process stream; cooling and condensing the copper-ligand complex byproduct of Cu<sup>+2</sup>(1,1,1,5,5,5-hexafluoro-2,4-pentanedionate<sup>-1</sup>)<sub>2</sub> to separate it from the process stream; contacting the copper-ligand complex byproduct of Cu<sup>+2</sup>(1,1,1,5,5,5-hexafluoro-2,4-pentanedionate<sup>-1</sup>)<sub>2</sub> with a protonation agent, such as: sulfuric acid, hydrochloric acid, hydroiodic acid, hydrobromic acid, trifluoroacetic acid, trifluoromethanesulfonic acid, acid ion exchange resin, hydrogen sulfide, water vapor and mixtures thereof; and recovering 1,1,1,5,5,5-hexafluoro-2,4-pentanedione.
Patent IL-133463-A0 (IL)
Title: Implant with deflector for intravascular dilation
IPC: A61F2/02
Filed: 1998-06-19
Abstract: An intravascular dilator includes a central body acting as deflector o the blood flow to increase the value of shear stress to the artery wall. Flexible spires soldered to the deflector are radially extensible from a first diameter substantially equal to the deflector diameter to a second diameter greater than the artery diameter, the spires rest against the artery internal wall in operative position.
Patent IL-136874-A0 (IL)
Title: Improved focus rings and methods therefor
IPC: C23C16/505
Filed: 1998-12-11
Abstract: An improved focus ring is configured for use in a plasma processing chamber. The focus ring is configured to overlap at least a portion of a substrate-holding chuck that is powered by radio frequency (RF) power during plasma operation to act as an electrode. The focus ring includes an upper surface that is exposed to a plasma region within the plasma processing chamber during the plasma operation. The focus ring further includes a chuck-overlapping portion that overlaps the portion of the substrate-holding chuck, at least a portion of the chuck-overlapping portion being formed of a first material having a lower dielectric constant than a remainder of the focus ring.
Patent IL-139576-A0 (IL)
Title: Biologically active composition
IPC: A61K9/08
Filed: 1999-05-12
Abstract: The invention relates to a novel biologically active composition which comprises a biologically active agent composition which comprises a biologically active agent to be released therefrom, said biologically active agent being dissolved and/or dispersed in a supersaturated state within a carrier, which carrier comprises a liquid and/or solid non-crystalline ester and/or polyester matrix, and where the precipitation of said biologically active agent is substantially, or completely, inhibited therein. Said supersaturated states is obtainable by subjecting one or more carrier staring substances(s) to such chemical reaction(s) that an ester and/or polyester matrix is provided, the biologically active agent being added after said chemical reaction(s) has (have) been completed.
Patent IL-144830-A0 (IL)
Title: Ribosomes structure and protein synthesis inhibitors
IPC: C07K14/195
Filed: 2001-08-09
Abstract: The invention provides methods for producing high resolution crystals of ribosomes and ribosomal subunits as well as crystals produced by such methods. The invention also provides high resolution structures of ribosomal subunits either alone or in combination with protein synthesis inhibitors. The invention provides methods for identifying ribosome-related ligands and methods for designing ligands with specific ribosome-binding properties as well as ligands that may act as protein synthesis inhibitors. Thus, the methods and compositions of the invention may be used to produce ligands that are designed to specifically kill or inhibit the growth of any target organism.